| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -9% |
| 3Y CAGR | +7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +459% |
| 3Y CAGR | +27% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,829.10 -45.70 (0.94%) | 22,321.46 | 30.36 | 5.31 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,640.50 -112.50 (1.45%) | 19,384.25 | 114.28 | 22.21 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,522.00 +41.50 (1.67%) | 18,855.46 | 27.81 | 5.26 | ||
Natco PharmaNATCOPHARM | ₹889.80 -13.35 (1.48%) | 16,162.87 | 11.39 | 1.75 |